Skip to main content

Table 1 Viability (A) and mortality (B) of the A. aegypti group treated with burchellin

From: Burchellin: study of bioactivity against Aedes aegypti

A

L3-L4

L4 - Pupae

Pupae -adult

L3-Adult

X ± SD

%

X ± SD

%

X ± SD

%

X ± SD

%

Control

10.0 ± 0

100

10.0 ± 0 a

100

10.0 ± 0 a

100

10.0 ± 0 a

100

Control 2

10.0 ± 0

100

10.0 ± 0 ab

100

10.0 ± 0 ab

100

10.0 ± 0 ab

100

0.5 μg/mL

10.0 ± 0

100

10.0 ± 0 ab

100

10.0 ± 0 ab

100

10.0 ± 0 ab

100

1 μg/mL

10.0 ± 0

100

10.0 ± 0 ab

100

10.0 ± 0 ab

100

10.0 ± 0 ab

100

5 μg/mL

10,0 ± 0

67

6.7 ± 1.5 c***

100

6.7 ± 1.5 c***

100

6.7 ± 1.5 c***

67

10 μg/mL

10.0 ± 0

63

6.3 ± 1.1 c***

100

6.3 ± 1.1 cd***

95

6.0 ± 1.0 cd***

60

20 μg/mL

10.0 ± 0

66

6.6 ± 0.6 c***

71

4.7 ± 0.6 d***

85

4.0 ± 1.0 d***

40

30 μg/mL

10.0 ± 0

13

1.3 ± 0.6 d***

0

0

0

0

0

B

Larvae

Pupae

X ± SD

VI

%

X ± SD

VI

%

Control

0

0

0

0

0

0

Control 2

0

0

0

0

0

0

0.5 μg/mL

0

0

0

0

0

0

1 μg/mL

0

0

0

0

0

0

5 μg/mL

3.3 ± 1.5 c**

3-3

33

0

0

0

10 μg/mL

3.6 ± 1.2 c***

2-2

37

0.3 ± 0.6

7-7

5

20 μg/mL

5.7 ± 0.2 c***

1-3

53

0.7 ± 0.6

7-7

14

30 μg/mL

10 ± 0 d***

1-3

100

-

-

-

  1. Burchellin treatment on A. aegypti at 0.5 – 30 μg/mL concentration. Values are mean ± standard deviation (X ± SD), average of three replicates of 10 larvae L3 per each group. Values followed by the same letter did not significantly different from each other, P > 0.05 when the Tukey test was used. Significance levels are represented as ***P < 0.001 and **P < 0.01 vs. Control 2 = Acetone control.